Using viruses to outsmart antibiotic-resistant bacteria – Phage Therapy
Phage therapy – the treatment of bacterial infections with viruses that attack those bacteria – was used in the...
FDA approves first treatment for congenital athymia
Congenital athymia is a rare condition in which babies are born without a thymus. As a result, the immune...
Using viruses to outsmart antibiotic-resistant bacteria
Phage therapy – the treatment of bacterial infections with viruses that attack those bacteria – was used in the...
Recent developments in therapy for HER2+ and HER2- Non-small cell lung cancer
Lung cancer kills more people worldwide than breast, prostate, colorectal, and brain cancers combined.1 Non-small cell lung cancer (NSCLC)...
Advances in our understanding of rosacea will help patients
Rosacea is a skin condition that affects the face, specifically the forehead, nose, cheeks, and chin.1,2 Patients often require...
Current and future paradigms in the management of Esophageal Cancer
In data released by GLOBOCAN 2020, stomach Cancer is the 5th biggest cancer in the world, with esophageal Cancer...
Cytokine-blocking monoclonal antibody helps prevent asthma exacerbations
A recent clinical trial showed a 56% reduction in yearly asthma exacerbations when patients with severe asthma were treated...
Beware cancer cells – the Oncolytic virus is coming for you!
The field of immunology is transforming the landscape for cancer patients. When you can get a T-cell into the...
Avapritinib approved by FDA for use in systemic mastocytosis
On June 16, 2021, the FDA approved a new targeted drug for advanced systemic mastocytosis, a group of rare...
Dapagliflozin approved for use in chronic kidney disease
The SGLT2 inhibitors, or gliflozins, have been rising stars in the fields of endocrinology and cardiology for their ability...